EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Performance of quantitative point-of-care tests to measure G6PD activity: An individual participant data meta-analysis

Arkasha Sadhewa iD, Ari Winasti Satyagraha, Mohammad Shafiul Alam, Wondimagegn Adissu, Anup Anvikar, Germana Bancone, Praveen K Bharti, Vinod K Bhutani, Santasabuj Das, Muzamil Mahdi Abdel Hamid, Mohammad Sharif Hossain, Nitika Nitika und 9 weitere

PLOS Neglected Tropical Diseases · 25.03.2025 · 19 (3) · e0012864

DOI: 10.1371/journal.pntd.0012864 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift PLOS Neglected Tropical Diseases, online erschienen am 25.03.2025. Verfasst von Arkasha Sadhewa und 20 weiteren Autor:innen. Beteiligte Einrichtung: Menzies School of Health Research and Charles Darwin University, Global and Tropical Health Division, Darwin, Australia. Hauptthemen laut MEDLINE: Glucosephosphate Dehydrogenase, Glucosephosphate Dehydrogenase Deficiency, Point-of-Care Testing, Point-of-Care Systems. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Charles Darwin International PhD Scholarships (CDIPS), Bill and Melinda Gates Foundation, NHMRC.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the main risk factor for severe haemolysis following treatment with 8-aminoquinolines (8AQ). The World Health Organization recommends G6PD testing prior to 8AQ-based hypnozoitocidal treatment.

Methods

We undertook an individual level meta-analysis of the performance of commercially available quantitative point-of-care diagnostics (PoCs) compared with reference spectrophotometry. A systematic literature search (PROSPERO: CRD42022330733) identified 595 articles of which 16 (2.7%) fulfilled pre-defined inclusion criteria and were included in the analysis, plus an additional 4 datasets. In total there were 12,678 paired measurements analyzed, 10,446 (82.4%) by STANDARD G6PD Test (SD Biosensor, RoK, [SDB]), 2,042 (16.1%) by CareStart G6PD Biosensor (AccessBio, USA, [CSA]), 150 (1.2%) by CareStart Biosensor (WellsBio, RoK [CSW]), and 40 (0.3%) by FINDER (Baebies, USA, [FBA]).

Findings

The pooled sensitivities of the SDB when measuring G6PD activity 88%). Only one study each for CSW and FBA was included. Sensitivities of the CSW were 0.04 (95% CI: 0.01-0.14) and 0.81 (95% CI: 0.71-0.89) at the 30% and 70% thresholds, respectively (venous blood samples). Sensitivities of the FBA were 1.00 (95% CI: 0.29-1.00) and 0.75 (95% CI: 0.19-0.99) at the 30% and 70% thresholds (venous blood samples). Specificities of the CSW and FBA were consistently high (>90%) at both thresholds. Accuracy of the SDB was higher in females at the 30% cut-off (OR: 3.49, p=0.002) and lower in malaria patients at the 70% cut-off (OR: 0.59, p = 0.005).

Conclusions

The SDB performed better than other PoCs. More evidence was available for the performance of the SDB compared to other PoCs, giving higher confidence in its utility in diagnosing G6PD deficiency.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glucosephosphate DehydrogenaseGlucosephosphate Dehydrogenase DeficiencyPoint-of-Care TestingPoint-of-Care SystemsHumansMaleSensitivity and SpecificityFemaleAdultAminoquinolines

Substanzen

Glucosephosphate Dehydrogenase8-aminoquinolineAminoquinolines

Autor:innen und Institutionen

  • Menzies School of Health Research and Charles Darwin University, Global and Tropical Health Division, Darwin, Australia.
  • Eijkman Research Center for Molecular Biology, National Research and Innovation Agency, Cibinong, Indonesia.
  • International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.
  • School of Medical Laboratory Sciences, Jimma University, Jimma, Ethiopia.
  • Clinical Trial Unit, Jimma University, Jimma, Ethiopia.
  • ICMR-National Institute of Malaria Research, New Delhi, India.

ORCID-Profile: Arkasha Sadhewa

Förderung

  • Charles Darwin International PhD Scholarships (CDIPS)
  • Bill and Melinda Gates Foundation
  • NHMRC
  • Charles Darwin University

Zitieren

APA

Sadhewa, A., Satyagraha, A. W., Alam, M. S., Adissu, W., Anvikar, A., Bancone, G., Bharti, P. K., Bhutani, V. K., Das, S., Hamid, M. M. A., Hossain, M. S., Nitika, N., Okech, B. A., Panggalo, L. V., Talukdar, A., von Fricken, M. E., Wong, R. J., Yilma, D., Price, R. N., …, & Ley, B. (2025). Performance of quantitative point-of-care tests to measure G6PD activity: An individual participant data meta-analysis. PLOS Neglected Tropical Diseases, 19(3), e0012864. https://doi.org/10.1371/journal.pntd.0012864

Vancouver

Sadhewa A, Satyagraha AW, Alam MS, Adissu W, Anvikar A, Bancone G, et al. Performance of quantitative point-of-care tests to measure G6PD activity: An individual participant data meta-analysis. PLOS Neglected Tropical Diseases. 2025;19(3):e0012864. doi:10.1371/journal.pntd.0012864

BibTeX
@article{Sadhewa2025,
  author = {Sadhewa, Arkasha and Satyagraha, Ari Winasti and Alam, Mohammad Shafiul and Adissu, Wondimagegn and Anvikar, Anup and Bancone, Germana and Bharti, Praveen K and Bhutani, Vinod K and Das, Santasabuj and Hamid, Muzamil Mahdi Abdel and Hossain, Mohammad Sharif and Nitika, Nitika and Okech, Bernard A and Panggalo, Lydia Visita and Talukdar, Arunansu and von Fricken, Michael E and Wong, Ronald J and Yilma, Daniel and Price, Ric N and Thriemer, Kamala and Ley, Benedikt},
  title = {Performance of quantitative point-of-care tests to measure G6PD activity: An individual participant data meta-analysis},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2025},
  volume = {19},
  number = {3},
  pages = {e0012864},
  doi = {10.1371/journal.pntd.0012864}
}
Kostenlos starten →